SII’s Covovax receives emergency approval for children aged 12-17 years
NEW DELHI: India’s drug regulator has granted restricted emergency use authorisation to Serum Institute’s COVID-19 vaccine Covovax for the 12-17...
NEW DELHI: India’s drug regulator has granted restricted emergency use authorisation to Serum Institute’s COVID-19 vaccine Covovax for the 12-17...
NEW DELHI: Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to market Nitroglycerin Sublingual...
NEW DELHI: The Union Cabinet, chaired by Prime Minister Narendra Modi was apprised of a Memorandum of Understanding (MoU) signed...
NEW DELHI: The Union Cabinet, chaired by Prime Minister Narendra Modi was apprised of a Memorandum of Understanding (MoU) signed...
NEW DELHI: The Union Cabinet, chaired by Prime Minister Shri Narendra Modi was apprised of a Memorandum of Understanding (MoU)...